SNMMI 2025

This two-part symposium will opened with representatives from a US community imaging center sharing how the decision to modernize their imaging services with high-performance PET/CT is impacting clinical results and facilitating a more efficient and effective experience for patients and users.

A second session focused on the emergence of new therapeutic strategies for Alzheimer’s disease and the clinical utility of PET/CT for diagnosis as well as the assessment of treatment efficacy.

Speakers:

• Russel L. Roberts, Jr., MD, Nuclear medicine physician, Rome Imaging Center, Rome, Georgia, USA
• Betty Harrell, R.T.(R)(N)(ARRT), Chief nuclear medicine technologist, Rome Imaging Center, Rome, Georgia, USA
• Jacob Dubroff, MD, PhD, Associate professor of radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Stay tuned for the video recording of the session which is coming soon.

Discover how two US theranostics programs are setting the standard in precision oncology with optimized molecular imaging protocols that enable effective and efficient cancer care without compromising patient comfort or high image quality.

Speakers:

• PET/CT utilization for appropriate patient selection and follow-up to optimize patient outcomes presented by Ryan Avery, MD, director of nuclear medicine, Northwestern Medicine, Chicago, Illinois, USA
• Quantitative SPECT/CT utilization for therapy response monitoring and dosimetry presented by Michael Morris, MD, founder and medical director, United Theranostics, Minneapolis, Minnesota, USA

Stay tuned for the video recording of the session which is coming soon.